Search results
Results from the WOW.Com Content Network
Blindsight is an experimental medical device developed by Neuralink. [ 1 ] [ 2 ] It has received Breakthrough Device Designation from the US Food and Drugs Administration (FDA) . [ 3 ] [ 4 ]
Neuralink Corp. [4] is an American neurotechnology company that has developed, as of 2024, implantable brain–computer interfaces (BCIs). It was founded by Elon Musk and a team of eight scientists and engineers (Max Hodak, Benjamin Rapoport, Dongjin Seo, Paul Merolla, Philip Sabes, Tim Gardner, Tim Hanson, and Vanessa Tolosa).
Noland Arbaugh (born 1993 or 1994) is an American quadriplegic known for being the first human recipient of Neuralink's brain-computer interface (BCI) implant. [1] He gained attention for his use of the device to regain digital autonomy after a spinal cord injury left him paralyzed.
The U.S. Securities and Exchange Commission (SEC) this week has reopened an investigation into Elon Musk's brain-chip startup Neuralink, according to a letter shared by Musk on Thursday on social ...
In 2016, Musk launched Neuralink with help from seven scientists and one engineer. Only two remain of the founding group—Musk and engineer DJ Seo. The goal of Neuralink is to develop brain ...
An animal testing laboratory at Elon Musk's Neuralink brain technology company was found to have "objectionable conditions or practices" by the Food and Drug Administration, which cited the ...
Elon Reeve Musk (/ ˈ iː l ɒ n /; born June 28, 1971) is a businessman known for his key roles in the space company SpaceX and the automotive company Tesla, Inc. His other involvements include ownership of X Corp., the company that operates the social media platform X (formerly Twitter), and his role in the founding of the Boring Company, xAI, Neuralink, and OpenAI.
Neuralink didn't respond to a request for comment from BI. The SEC is investigating how Musk bought shares in Twitter ahead of his $44 billion acquisition of the social network.